Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/17543
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLekskulchai V.
dc.date.accessioned2022-03-10T13:17:27Z-
dc.date.available2022-03-10T13:17:27Z-
dc.date.issued2021
dc.identifier.issn23254416
dc.identifier.other2-s2.0-85121343211
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/17543-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85121343211&partnerID=40&md5=091fcff0e6af7a3567701a88e93e6b18
dc.description.abstractBACKGROUND Because reliable epidemiological data are necessary to eliminate hepatitis B and C virus (HBV and HCV) infections, factors influencing their prevalence should be determined. This study aimed to disclose practical issues that affect the prevalence of these viral infections. MATERIAL AND METHODS All medical records with laboratory findings during 2016 to 2018 were reviewed, and all relevant data were extracted. All HBV and HCV infections were followed within these 3 years and investigated in detail. RESULTS The total number of records was 103 197, with a male to female ratio of 1: 1.4. Hepatitis B surface antigen (HBsAg) was tested in 12 934 cases, with a male to female ratio of 1: 2.6. Anti-HCV antibody (anti-HCV Ab) testing was done in 475 cases (53% male). The seroprevalence of HBV and HCV was 5.2% and 4.4%, respectively. Chronic HBV and HCV infections and their life-threatening complication, liver cancer, were highly detected in men aged 41-60 years. CONCLUSIONS HBsAg was highly screened in women owing to the nationwide implementation of the universal HBsAg screening in pregnant women to prevent vertical transmission. Screening for anti-HCV Ab was neglected, probably due to lack of vaccine and high costs of anti-HCV drugs, which most people in low- to middle-income countries generally cannot afford. Local practices under national health care policies and limited budget and resources can cause underestimation of the prevalence of the HBV and HCV infections and persistent transmission of these viruses owing to unidentified cases.
dc.languageen
dc.subjecthepatitis B surface antigen
dc.subjecthepatitis C antibody
dc.subjectadult
dc.subjectfemale
dc.subjecthealth care delivery
dc.subjecthealth care policy
dc.subjectHepacivirus
dc.subjecthepatitis B
dc.subjecthepatitis C
dc.subjecthuman
dc.subjectimmunology
dc.subjectmale
dc.subjectmiddle aged
dc.subjectpregnancy
dc.subjectprevalence
dc.subjectseroepidemiology
dc.subjectAdult
dc.subjectDelivery of Health Care
dc.subjectFemale
dc.subjectHealth Policy
dc.subjectHepacivirus
dc.subjectHepatitis B
dc.subjectHepatitis B Surface Antigens
dc.subjectHepatitis C
dc.subjectHepatitis C Antibodies
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPregnancy
dc.subjectPrevalence
dc.subjectSeroepidemiologic Studies
dc.titlePrevalence of Hepatitis B and C Virus Infections: Influence of National Health Care Policies and Local Clinical Practices
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationMedical science monitor basic research. Vol 27, No. (2021), p.e933692-
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.